As of Oct 9, 2026 close
- Market cap
- $4.68M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.63$19.00
- Volume (live)
- -
- Avg. volume (3M)
- 27.02K
NeuroSense Therapeutics (NRSN) Stock Price & Financial Analysis
NeuroSense Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.61 - $3.85 |
|---|---|
| 52-Week High | $19.00 |
| 52-Week Low | $0.63 |
| Open | $3.61 |
| Volume (last close) | 15.41K |
| Average Volume (3M) | 27.02K |
| Market Cap | 4.68M |
|---|---|
| Shares Outstanding | 1.28M |
| Price to Book (P/B) | -2.93 |
| EV/EBITDA | -0.38 |
| 50-Day MA | $7.51 |
|---|---|
| 200-Day MA | $4.48 |
| 1-Year Change | +186.40% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
NeuroSense Therapeutics at a Glance
NeuroSense Therapeutics (NRSN) has a market capitalization of $4.68M.
It holds $166.00K in cash and securities against $170.00K of debt, a net debt position of $4.00K.
NeuroSense Therapeutics does not currently pay a dividend.
The share price is up 186.4% over the past year. At $3.66 it sits within its 52-week range of $0.63 to $19.00, below its 200-day moving average of $4.48.
Frequently Asked Questions About NeuroSense Therapeutics
What is the current stock price for NRSN?
As of the Oct 9, 2026 close, NRSN stock trades at $3.66. The 52-week range is $0.63–$19.00, with a day range of $3.61–$3.85.
What is the P/E ratio for NRSN?
The P/E ratio (Price-to-Earnings) for NRSN is shown in the Key Statistics section. This valuation metric helps compare NeuroSense Therapeutics Ltd. to industry peers.
Does NRSN pay dividends?
NeuroSense Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for NRSN?
Analyst ratings and recommendations for NRSN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NRSN?
NeuroSense Therapeutics's market capitalization is $4.7M, classifying it as a micro-cap company. NeuroSense Therapeutics operates in the Healthcare sector within the Biotechnology industry.